We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+24.06%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$108B
AUM Growth
+$19.3B
(+22%)
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
28.24%
Holding
1,469
New
74
Increased
884
Reduced
437
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pan American Silver
PAAS
|
+$495M |
| 2 |
Royal Gold
RGLD
|
+$441M |
| 3 |
Equinox Gold
EQX
|
+$364M |
| 4 |
Alamos Gold
AGI
|
+$339M |
| 5 |
Texas Instruments
TXN
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$1.23B |
| 2 |
Agnico Eagle Mines
AEM
|
+$716M |
| 3 |
B
Barrick Mining
B
|
+$505M |
| 4 |
Wheaton Precious Metals
WPM
|
+$442M |
| 5 |
TSMC
TSM
|
+$360M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.24% |
| 2 | Materials | 27.94% |
| 3 | Industrials | 7.78% |
| 4 | Healthcare | 5.71% |
| 5 | Financials | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Avantor
AVTR
$9.25B
| $94K | ﹤0.01% |
7,068
+201
| +3% | +$2.59K |
|
|
CVGW
1327
DELISTED
Calavo Growers
CVGW
| $94K | ﹤0.01% |
3,648
+685
| +23% | +$18.5K |
|
1328
Seneca Foods Class A
SENEA
$1.15B
| $88K | ﹤0.01% |
818
+211
| +35% | +$22.3K |
|
1329
Sasol
SSL
$7.21B
| $84K | ﹤0.01% |
13,541
+12,365
| +1,051% | +$72.3K |
|
|
RERE
1330
ATRenew
RERE
$944M
| $83K | ﹤0.01% |
+17,939
| New | +$72.2K |
|
1331
Fomento Económico Mexicano
FMX
$42.8B
| $82K | ﹤0.01% |
829
+96
| +13% | +$8.92K |
|
1332
Ultragenyx Pharmaceutical
RARE
$2.46B
| $80K | ﹤0.01% |
2,650
+549
| +26% | +$16.5K |
|
1333
Grupo Aeroportuario del Pacifico
PAC
$13B
| $79K | ﹤0.01% |
334
+57
| +21% | +$13.7K |
|
1334
Invesco
IVZ
$13.6B
| $76K | ﹤0.01% |
3,298
-4,061
| -55% | -$84.3K |
|
1335
Invesco QQQ Trust
QQQ
$469B
| $76K | ﹤0.01% |
126
+48
| +62% | +$27.5K |
|
1336
Kanzhun
BZ
$7.36B
| $74K | ﹤0.01% |
3,173
+1,062
| +50% | +$22.8K |
|
1337
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $68K | ﹤0.01% |
702
-48
| -6% | -$4.59K |
|
|
PINC
1338
DELISTED
Premier
PINC
| $67K | ﹤0.01% |
2,408
+495
| +26% | +$12K |
|
1339
Banco Macro
BMA
$5.93B
| $65K | ﹤0.01% |
+1,692
| New | +$103K |
|
|
HPP
1340
Hudson Pacific Properties
HPP
$786M
| $64K | ﹤0.01% |
3,299
+141
| +4% | +$2.66K |
|
|
AXON
1341
Axon Enterprise
AXON
$46.4B
| $60K | ﹤0.01% |
+83
| New | +$63K |
|
1342
Hilton Worldwide
HLT
$70.7B
| $60K | ﹤0.01% |
+233
| New | +$63K |
|
1343
Beam Therapeutics
BEAM
$2.67B
| $52K | ﹤0.01% |
2,158
+707
| +49% | +$14.1K |
|
|
PDCO
1344
DELISTED
Patterson Companies, Inc.
PDCO
| $48K | ﹤0.01% |
1,527
| – | – |
|
1345
New Jersey Resources
NJR
$5.86B
| $47K | ﹤0.01% |
968
-536
| -36% | -$25K |
|
1346
Adecoagro
AGRO
$1.37B
| $46K | ﹤0.01% |
5,931
-16,765
| -74% | -$147K |
|
1347
Intellia Therapeutics
NTLA
$1.5B
| $46K | ﹤0.01% |
2,640
+633
| +32% | +$7.8K |
|
|
FOLD
1348
DELISTED
Amicus Therapeutics
FOLD
| $44K | ﹤0.01% |
5,638
+1,466
| +35% | +$10.4K |
|
|
LKFT
1349
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
| $42K | ﹤0.01% |
1,218
+107
| +10% | +$3.42K |
|
1350
Omnicell
OMCL
$1.71B
| $40K | ﹤0.01% |
1,310
+254
| +24% | +$7.81K |
|
Similar funds
VanEck Associates's Q3 2025 Portfolio in Review
As of Q3 2025, VanEck Associates held 1,469 positions worth $108B, up 22% from $88.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
VanEck Associates's Q3 2025 filing shows 74 new, 884 increased, 437 reduced and 36 closed positions. Its largest new stake was Roper Technologies: 401,069 shares worth $200M. The largest sale was Newmont, an estimated $1.23B.
By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 43% a quarter earlier, followed by Materials and Industrials.
- VanEck Associates's largest Q3 2025 buy was Roper Technologies: 401,069 shares worth $200M.
- VanEck Associates added most to Pan American Silver in Q3 2025, an estimated $495M increase.
- VanEck Associates's biggest Q3 2025 reduction was Newmont, cutting an estimated $1.23B.
- VanEck Associates fully exited Vanguard Total World Stock ETF in Q3 2025, selling an estimated $105M.
- VanEck Associates's ten largest holdings make up 28% of its $108B portfolio in Q3 2025.
- VanEck Associates opened 74 new positions and closed 36 in Q3 2025.
- VanEck Associates's portfolio value rose 22% quarter-over-quarter to $108B.
Based on VanEck Associates's 13F filing for Q3 2025, filed 13 Nov 2025.